Interaction Between Cocaine and Quetiapine - 1
This trial is active, not recruiting.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|Start date||October 2003|
|Trial size||12 participants|
|Trial identifier||NCT00087750, NIDA-MDS-0001-1|
The purpose of this study is to assess the safety of intravenous (IV) cocaine in subjects taking quetiapine at 3 dosage levels.
|Endpoint classification||safety study|
Male or female participants from 18 years up to 45 years old.
Inclusion Criteria: Includes but is not limited to: non-treatment seeking individuals. Must meet DSM-IV criteria for cocaine abuse or dependence. Must be able to verbalize understanding of consent and provide written informed consent and verbalize willingness to complete study procedures. Site will provide further details. Exclusion Criteria: Please contact site for further information
|Official title||Interaction Between IV Cocaine and Quetiapine|
|Principal investigator||Domenic Ciraulo, M.D.|
|Description||A placebo-controlled, double-blind, inpatient assessment of interaction between intravenous cocaine and quetiapine (seroquel) in cocaine-experienced subjects. To assess the safety of IV cocaine in subjects taking quetiapine at 3 dosage levels.|
Call for more information